Med Business World

Your source for healthcare business

CEO

Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders

Gabather AB (Nasdaq First North Growth Market: GABA) today reports that two new US provisional patent applications based on novel findings from the EEG/fMRI target engagement study with GT-002, a selective positive allosteric GABAA-receptor modulator. The inventions relate to the…

Venus Remedies awarded its first incentive of Rs.7.50 cr. under PLI scheme

Venus Remedies Ltd, one of India’s leading manufacturers of generic drugs, has been awarded its first disbursement of Rs 7.5 crore under the Central government’s Production Linked Incentive (PLI) scheme for the financial year 2022-23, which covers 75% of the…

Venus Remedies gets coveted GMP certification from Libya

Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in…

Venus Remedies gets coveted GMP certification from Libya

Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in…

Synthego Bridges Critical Preclinical Gap to Accelerate CRISPR-based Cell and Gene Therapies

Synthego, a leading provider of genome engineering solutions, today announced the launch of its IND-enabling (INDe) gRNAs, a transformative product offering that revolutionizes the CRISPR-based cell and gene therapy preclinical pipeline. This innovative offering empowers researchers with high quality gRNAs…

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

WuXi Vaccines, a leading contract development and manufacturing organization (CDMO) focused on vaccine discovery, development, and manufacturing, has launched its first standalone vaccines CDMO site in Suzhou, China. The opening will add drug substance and drug product capacity, with end-to-end…

Tampa General Hospital Named One of Newsweek’s Best Smart Hospitals for 2024

Tampa General Hospital (TGH) has been recognized as one of the World’s Best Smart Hospitals for 2024 by Newsweek and Statista. This prestigious global accolade is a testament to Tampa General’s commitment to harnessing cutting-edge technology to enable world-class patient…

Tyra Biosciences to Participate at 2023 Cantor Global Healthcare Conference

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that management will participate at the 2023 Cantor Global Healthcare Conference, taking…

Shine Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies using Terbium and Lutetium

The strategic collaboration between Curadh MTR Inc. and SHINE Technologies marks a pivotal moment in the advancement of cancer therapies. This alliance promises to harness the potential of radioisotopes using Terbium and Lutetium to target and eliminate cancer cells with…

MediBuddy Secures $18 Million Funding to Drive Strategic Acquisitions and Continued Expansion

MediBuddy, India’s largest digital healthcare platform, secures additional funding of $18 million, reaffirming unwavering support from the existing investors Quadria Capital, Lightrock, and TEAMFund. This infusion of equity capital, amplifies MediBuddy’s steadfast dedication to growth and expansion through strategic acquisitions….